Qualitative and quantitative analysis of 18F-GP1 positron emission tomography in thrombotic cardiovascular disease

Beth Whittington1, Evangelos Tzolos2, Shruti Joshi2

  • 1BHF Centre for Cardiovascular Science, University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK. bwhittin@ed.ac.uk.

Scientific Reports
|November 5, 2024
PubMed

Insights

This study shows that the novel radiotracer 18F-GP1 has excellent observer repeatability for detecting activated platelets and thrombi in coronary, carotid, and cerebral vessels. These findings support its use in diagnosing conditions like myocardial infarction and ischemic stroke.

Area of Science:

  • Nuclear Medicine
  • Cardiovascular Imaging
  • Neurology

Background:

  • Activated platelets and thrombi are key in acute myocardial infarction (AMI) and ischemic stroke.
  • Novel radiotracers are needed for precise imaging of these pathological processes.
  • 18F-GP1 is a new radiotracer targeting activated platelets and thrombus.

Purpose of the Study:

  • To assess the observer repeatability of coronary, carotid, and cerebral 18F-GP1 uptake.
  • To evaluate both qualitative and quantitative measurements of 18F-GP1 uptake in patients with AMI or ischemic stroke.

Main Methods:

  • Forty-three patients with acute myocardial infarction or ischemic stroke underwent hybrid positron emission tomography (PET) and computed tomography (CT) angiography.
  • Qualitative and quantitative assessments of 18F-GP1 uptake were performed on coronary arteries, carotid arteries, and brain parenchyma.
  • Intraobserver and interobserver agreement for SUVmax and TBRmax were analyzed.

Main Results:

  • Excellent intraobserver and interobserver agreement for qualitative 18F-GP1 uptake (presence/absence).
  • Excellent intraobserver repeatability for quantitative SUVmax and TBRmax in all analyzed vascular beds (ICC ≥ 0.92).
  • Good interobserver repeatability for quantitative SUVmax and TBRmax (ICC ≥ 0.89), with strongest agreement in brain parenchyma.

Conclusions:

  • 18F-GP1 PET-CT imaging demonstrates robust and repeatable qualitative and quantitative measurements.
  • The tracer reliably detects activated platelets and thrombi in coronary, carotid, and cerebral vasculature.
  • These findings support the clinical utility of 18F-GP1 for diagnosing thrombotic events.

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
88
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
3
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3